Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Patent
1989-12-01
1991-09-17
Page, Thurman
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
424434, 264 41, A61K 3722, A61F 1300, B01J 1302
Patent
active
050493892
ABSTRACT:
A non-conventional lipid particle formulation for the sustained release and delivery of steroids into deep lung is disclosed. The formulation provides prolonged release of the drug, improved therapeutic ratio, lower toxicity, reduced systemic side effects, and stability for several months. The formulation is in particular suitable for treatment of interstitial lung diseases.
REFERENCES:
patent: 4217344 (1980-08-01), Vanlerberghe et al.
patent: 4484577 (1984-11-01), Sackner et al.
patent: 4649911 (1987-03-01), Knight et al.
patent: 4823784 (1989-04-01), Bordoni et al.
patent: 4849227 (1989-07-01), Cho
patent: 4897308 (1990-01-01), Vanlerberghe et al.
patent: 4906476 (1990-03-01), Radhakrishnan
J. Microencapsulation 4:189-200 (1987), Inhalation Study Techniques, pp. 9-31, R. F. Phalen, Editor, CRC Press (1984).
New Eng. J. Med. 315:870 (1986).
Amer. Rev. Resp. Dis. 41:A349 (1988).
Eur. Resp. J. 2:218 (1988).
Eur. J. Resp. Dis. 68:19 (1988).
Biochemistry 17:3759 (1978).
Biochim. Biophsy. Acta 691:227 (1982).
Dehlinger Peter J.
Dolezalova Hana
Kishore G. S.
Liposome Technology, Inc.
Page Thurman
LandOfFree
Novel liposome composition for the treatment of interstitial lun does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel liposome composition for the treatment of interstitial lun, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel liposome composition for the treatment of interstitial lun will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1916024